<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1613072</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2025.1613072</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Electrophysiological classification of <italic>CACNA1G</italic> gene variants associated with neurodevelopmental and neurological disorders</article-title>
<alt-title alt-title-type="left-running-head">Davakan et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2025.1613072">10.3389/fphar.2025.1613072</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Davakan</surname>
<given-names>Ama&#xeb;l</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Cmarko</surname>
<given-names>Leos</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ribeiro Oliveira-Mendes</surname>
<given-names>Barbara</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1577811/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bernat</surname>
<given-names>Claire</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boulali</surname>
<given-names>Najlae</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Montnach</surname>
<given-names>J&#xe9;r&#xf4;me</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/607507/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vallee</surname>
<given-names>Stephanie E.</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3110619/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dinulos</surname>
<given-names>Mary B.</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Burglen</surname>
<given-names>Lydie</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cantagrel</surname>
<given-names>Vincent</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/217512/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Weiss</surname>
<given-names>Norbert</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3104542/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nicole</surname>
<given-names>Sophie</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Monteil</surname>
<given-names>Arnaud</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/136748/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>De Waard</surname>
<given-names>Michel</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/883293/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Lory</surname>
<given-names>Philippe</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3889/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>IGF, Universit&#xe9; de Montpellier, CNRS, INSERM</institution>, <addr-line>Montpellier</addr-line>, <country>France</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>LabEx &#x2018;Ion Channel Science and Therapeutics&#x2019;</institution>, <addr-line>Montpellier</addr-line>, <country>France</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Nantes Universit&#xe9;, CNRS, INSERM, l&#x2019;Institut du Thorax</institution>, <addr-line>Nantes</addr-line>, <country>France</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Pathophysiology, Third Faculty of Medicine, Charles University</institution>, <addr-line>Prague</addr-line>, <country>Czechia</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University</institution>, <addr-line>Prague</addr-line>, <country>Czechia</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Department of Pediatrics and Clinical Genetics, Dartmouth-Hitchcock Medical Center and Clinics</institution>, <addr-line>Lebanon</addr-line>, <addr-line>NH</addr-line>, <country>United States</country>
</aff>
<aff id="aff7">
<sup>7</sup>
<institution>Developmental Brain Disorders, Laboratory, Imagine Institute, Universit&#xe9; Paris Cit&#xe9;, INSERM UMR1163</institution>, <addr-line>Paris</addr-line>, <country>France</country>
</aff>
<aff id="aff8">
<sup>8</sup>
<institution>Pediatric Neurogenetics Laboratory, Department of Genetics, Armand-Trousseau Hospital, APHP, Sorbonne University</institution>, <addr-line>Paris</addr-line>, <country>France</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/16583/overview">Jean-Fran&#xe7;ois Desaphy</ext-link>, University of Bari Aldo Moro, Italy</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1133/overview">Terrance P. Snutch</ext-link>, University of British Columbia, Canada</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2255269/overview">Laurent Ferron</ext-link>, University of Calgary, Canada</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Philippe Lory, <email>philippe.lory@igf.cnrs.fr</email>
</corresp>
<fn fn-type="equal" id="fn001">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors share first authorship</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>02</day>
<month>10</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>16</volume>
<elocation-id>1613072</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>04</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>09</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Davakan, Cmarko, Ribeiro Oliveira-Mendes, Bernat, Boulali, Montnach, Vallee, Dinulos, Burglen, Cantagrel, Weiss, Nicole, Monteil, De Waard and Lory.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Davakan, Cmarko, Ribeiro Oliveira-Mendes, Bernat, Boulali, Montnach, Vallee, Dinulos, Burglen, Cantagrel, Weiss, Nicole, Monteil, De Waard and Lory</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>This study highlights the complementarity of automated patch-clamp (APC) and manual patch-clamp (MPC) approaches to describe the electrophysiological properties of eighteen Ca<sub>v</sub>3.1 calcium channel variants associated with various neurological conditions. Current density was measured efficiently for all variants in APC experiments, with four variants (p.V184G, p.N1200S, p.S1263A and p.D2242N) showing elevated current densities, compared to wild-type Ca<sub>v</sub>3.1 channel, while six variants (p.M197R, p.V392M, p.F956del, p.I962N, p.I1412T, and p.G1534D) displayed reduced current densities, and were therefore preferentially studied using MPC. The electrophysiological properties were well preserved in APC (e.g., inactivation and deactivation kinetics, steady-state properties), with only the APC-MPC correlation for activation kinetics being less robust. In addition, neuronal modeling, using a deep cerebellar neuron (DCN) environment, revealed that most of the variants localized to the intracellular gate (S5 and S6 segments) could increase DCN spike frequencies. This DCN firing was highly dependent on current density and further pointed to the gain-of-function (GOF) properties of p.A961T and p.M1531V, the two recurrent variants associated with Spinocerebellar Ataxia type-42 with Neurodevelopmental Deficit (SCA42ND). Action-potential (AP) clamp experiments performed using cerebellar and thalamic neuron activities further established the GOF properties of p.A961T and p.M1531V variants. Overall, this study demonstrates that APC is well-suited for high-throughput analysis of Ca<sub>v</sub>3.1 channel variants, and that MPC complements APC for characterizing low-expression variants. Furthermore, <italic>in silico</italic> modeling and AP clamp experiments reveal that the gain- or loss-of-function properties of the variants are determined by how the Ca<sub>v</sub>3.1 channel decodes the electrophysiological context of a neuron.</p>
</abstract>
<kwd-group>
<kwd>calcium channel</kwd>
<kwd>SCA42ND</kwd>
<kwd>electrophysiology</kwd>
<kwd>automated patch-clamp</kwd>
<kwd>Cav3.1</kwd>
</kwd-group>
<counts>
<page-count count="14"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Pharmacology of Ion Channels and Channelopathies</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>The T-type calcium channels (Ca<sub>v</sub>3.1, Ca<sub>v</sub>3.2 and Ca<sub>v</sub>3.3) are voltage-gated calcium channels with some unique features, notably their activation by low plasma membrane depolarization (low-voltage activated) and exhibiting fast inactivation (<xref ref-type="bibr" rid="B34">Zamponi et al., 2015</xref>; <xref ref-type="bibr" rid="B18">Lory et al., 2020</xref>). The Ca<sub>v</sub>3.1 channel is expressed in many types of neurons, from the cerebellum, thalamus and cortex, and contributes to neuronal excitability, especially rebound burst firing (<xref ref-type="bibr" rid="B26">Perez-Reyes, 2003</xref>). Several variants in <italic>CACNA1G</italic>, the gene encoding Ca<sub>v</sub>3.1 channels, are associated with neurological conditions, mainly cerebellar and neurodevelopmental disorders, including SCA42 (spinocerebellar ataxia type 42; (<xref ref-type="bibr" rid="B8">Coutelier et al., 2015</xref>)), SCA42ND (SCA42 with neurodevelopmental deficits; (<xref ref-type="bibr" rid="B7">Chemin et al., 2018</xref>)), and developmental and epileptic encephalopathy (DEE; (<xref ref-type="bibr" rid="B3">Berecki et al., 2020</xref>)). Aside from SCA42, most of these recently reported Ca<sub>v</sub>3.1 variants are <italic>de novo</italic> missense variants that greatly alter the biophysical properties of the Ca<sub>v</sub>3.1 channel (<xref ref-type="bibr" rid="B18">Lory et al., 2020</xref>). This is well exemplified for the first two variants identified in SCA42ND patients, p.A961T and p.M1531V, which localized within the intracellular gate (IG) at the IIS6 and IIIS6 segments, respectively. These variants are responsible for a slowing in the inactivation and deactivation kinetics as well as an increase in the window current (<xref ref-type="bibr" rid="B7">Chemin et al., 2018</xref>). Recently, several novel Ca<sub>v</sub>3.1 variants (p.M197R, p.V392M, p.F956del, p.I962N, p.S1263A, p.I1412T, p.G1534D and p.R1718G) were reported in patients with neurodevelopmental conditions, either fully or partially overlapping the original SCA42ND presentation (<xref ref-type="bibr" rid="B27">Qebibo et al., 2024</xref>). All these findings have established <italic>CACNA1G</italic> as involved in a broad spectrum of neurological and neurodevelopmental diseases.</p>
<p>Patch-clamp recordings of Ca<sub>v</sub>3.1 variants heterologously expressed in HEK-293 cells is a gold-standard for electrophysiological characterization of disease variants (<xref ref-type="bibr" rid="B7">Chemin et al., 2018</xref>). However, given the growing number of Ca<sub>v</sub>3.1 variants identified, conducting calcium current recordings using manual patch-clamp (MPC) appear fastidious, highlighting the need for medium/high-throughput electrophysiology for such characterization. Automated patch-clamp (APC) was recently employed for the investigation of disease-associated variants in sodium and potassium channels (<xref ref-type="bibr" rid="B33">Yajuan et al., 2012</xref>; <xref ref-type="bibr" rid="B15">Jiang et al., 2022</xref>; <xref ref-type="bibr" rid="B32">Vanoye et al., 2022</xref>; <xref ref-type="bibr" rid="B21">Ma et al., 2024</xref>). This approach was also used to investigate multiple variants associated with schizophrenia risk in the Ca<sub>v</sub>3.3 channel (<xref ref-type="bibr" rid="B2">Baez-Nieto et al., 2022</xref>). Not only can most MPC protocols be adapted for APC to ensure accurate electrophysiological characterization of recombinant Ca<sub>v</sub>3 channels, but APC also offers specific advantages, such as simultaneous recordings of a large number of cells (<xref ref-type="bibr" rid="B22">Montnach et al., 2021</xref>).</p>
<p>In this study, we provide the electrophysiological characterization of 18 Ca<sub>v</sub>3.1 variants, including 6 newly reported variants. APC and MPC approaches were used jointly to validate the experimental conditions in APC experiments, including the efficiency of transient transfection to record Ca<sub>v</sub>3.1 current, and the necessary adjustments of the external (5.2&#xa0;mM vs. 2&#xa0;mM CaCl<sub>2</sub>) and intracellular (CsF vs. CsCl) recording solutions. APC enabled accurate assessment of Ca<sub>v</sub>3.1 current density, while MPC proved more effective for studying low-expressing variants. Neuronal modeling, using the deep cerebellar neuron (DCN) framework, along with action-potential clamp experiments were further carried out to functionally classify all these variants as loss-of-function (LOF), unchanged, or gain-of-function (GOF). This analysis further confirmed the strong GOF properties of p.A961T and p.M1531V, the two recurrent variants in SCA42ND.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and methods</title>
<sec id="s2-1">
<title>Directed mutagenesis</title>
<p>The human <italic>CACNA1G</italic> complementary DNA (accession number NM_198387.2) was mutated to generate the 18 variants by using a site-directed mutagenesis service (GenScript Biotech, Netherlands). The protein variant nomenclature used here (e.g., p.A961T) is based on the UniProt protein sequence O43497 that corresponds to the full-length reference transcript, and is simplified in the Figures (A961T) for an easier reading of the panels. The plasmid expression vectors (pcDNA3-based) were then amplified to reach the necessary dilution, 6&#xa0;&#x3bc;g/&#x3bc;L for transfections for the APC experiments and 1&#xa0;&#x3bc;g/&#x3bc;L for transfections for the MPC experiments.</p>
</sec>
<sec id="s2-2">
<title>Transient transfection</title>
<p>Transient transfection was performed in 35&#xa0;mm Petri dishes. For MPC, HEK-293T cells were transfected using jet-PEI (QBiogen) with a 2&#xa0;&#xb5;g plasmid DNA mix containing 1% of a GFP-encoding construct and 99% of a Ca<sub>v</sub>3.1-encoding construct, either wild-type (WT) or variants channels. For APC, HEK-293 cells were transfected by electroporation using the MaxCyte STx system (MaxCyte Inc., USA). For each condition (WT and variants), 25&#xa0;&#xb5;g of plasmid per transfection was used. Thirty hours after transfection, cells were dissociated with Accutase, diluted and transferred into the patch-clamp apparatus. Two independent tranfections (at least) were done for each variants measured in APC experiments, and the trend was always conserved between these 2 sets of experiments (success rate, current density, biophysical parameters). WT was included in every set of experiments, to control consistency between sets of experiments and enable data normalization. Expression level and current properties were well conserved for WT among all the series of transfection.</p>
</sec>
<sec id="s2-3">
<title>Automated patch clamp (APC)</title>
<p>APC recordings were performed using the SyncroPatch 384PE from Nanion (Munich, Germany). Whole-cell T-type currents were recorded in transiently transfected HEK-293 cells. Single-hole, 384-well recording chips were used and seeded with 300,000 cells/mL. Pulse generation and data collection were performed with the PatchControl384 v1.5.2 software (Nanion) and the Biomek v1.0 interface (Beckman Coulter). After initiating the experiment, cell catching, sealing, whole-cell formation, buffer exchanges, recording, and data acquisition were all performed sequentially and automatically. The recording solutions were purchased from Nanion. The intracellular solution contained (in mM): 10 CsCl, 110 CsF, 10 NaCl, 10 EGTA, and 10 HEPES (pH 7.2). The extracellular solution contained (in mM): 140 NaCl, 4 KCl, 1 MgCl<sub>2</sub>, 5 Glucose, 10 HEPES (pH 7.4) with the final concentration of CaCl<sub>2</sub> adjusted to 5.2&#xa0;mM. This concentration was chosen to obtain greater calcium current density and higher percentage of gigaseal recordings. Whole-cell experiments were performed at a holding potential of &#x2212;100&#xa0;mV at room temperature (23&#xa0;&#xb0;C). For APC, series resistance (Rs) was compensated by maximum 80% and/or 20 MOhm to minimize voltage errors, and capacitance was compensated using Nanion&#x2019;s compensation and correction. Currents were sampled at 20&#xa0;kHz. Activation and inactivation curves were built using depolarization steps lasting 3,000&#xa0;ms from &#x2212;120&#xa0;mV to &#x2b;10&#xa0;mV, with 5&#xa0;mV increments followed by a 200&#xa0;ms depolarization step to &#x2212;20&#xa0;mV. Deactivation curves were built with a 20&#xa0;ms pulse to &#x2212;20&#xa0;mV followed by 200&#xa0;ms hyperpolarizing pulses from &#x2212;120&#xa0;mV to &#x2212;60&#xa0;mV. The recovery from inactivation was investigated using a double pulse protocol. Cells were first depolarized by a 1,000&#xa0;ms pre-pulse at &#x2212;20&#xa0;mV followed by a 20&#x2013;7,000&#xa0;ms long interpulse interval at holding potential (&#x2212;100&#xa0;mV), and finally depolarized by a 100&#xa0;ms test pulse at &#x2212;20&#xa0;mV.</p>
</sec>
<sec id="s2-4">
<title>Manual clamp (MPC) and action potential (AP) clamp</title>
<p>Two days after transfection, cells were split at low density for whole-cell calcium current recordings using the patch-clamp technique with an Axopatch 200B amplifier (Molecular Devices). Borosilicate glass patch pipettes were used with a resistance of 1.5&#x223c;2.5 MOhm when filled with an internal solution containing (in mM): 140 CsCl, 10 EGTA, 10 HEPES, and 3 CaCl<sub>2</sub> (pH adjusted to 7.25 with NaOH, &#x223c;315&#xa0;mOsm). The extracellular solution contained (in mM): 135 NaCl, 20 TEACl, 2CaCl<sub>2</sub>, 1 MgCl<sub>2</sub> and 10 HEPES (pH adjusted to 7.25 with NaOH 1M, &#x223c;330&#xa0;mOsm). Recordings were filtered at 5&#xa0;kHz. Series resistance (Rs) was compensated by 70%&#x2013;80% to minimize voltage errors, and pipette and membrane capacitances were compensated using the built-in circuitry prior to data acquisition. Current traces were recorded from a holding potential (HP) of &#x2212;100&#xa0;mV to ensure full availability of Cav3.1 channels upon depolarization. Depolarizing test pulses (TPs) were then applied to elicit Cav3.1 currents at various membrane potentials (Vm), allowing the construction of current&#x2013;voltage (I&#x2013;V) relationships by plotting the maximum peak current magnitude, normalized by the cell capacitance, as a function of the voltage applied. The steady-state inactivation properties were determined using a 5-s conditioning pre-pulses ranging from &#x2212;130&#xa0;mV to &#x2212;40&#xa0;mV, followed by a test pulse (TP) at &#x2212;30&#xa0;mV, allowing quantification of the percentage of inactivation at each conditioning potential and determination of the half-inactivation potential (<italic>V</italic>
<sub>
<italic>0.5inact</italic>
</sub>). For the action-potential clamp studies performed in MPC, the stimulation commands were (1) a regular train of spikes recorded in Purkinje neurons of the cerebellum generously provided by Dr B. P. Bean (Harvard Medical School, Boston, MA, USA) (<xref ref-type="bibr" rid="B28">Raman and Bean, 1997</xref>), and (2) a reticular thalamic neuron (nRT) rebound burst (<xref ref-type="bibr" rid="B6">Chemin et al., 2002</xref>).</p>
</sec>
<sec id="s2-5">
<title>Analysis of APC and MPC recordings</title>
<p>The voltage&#x2013;conductance relationship G<sub>(V)</sub> was obtained by dividing the maximum current amplitude by the corresponding driving force with the reversal potential (V<sub>Rev</sub>) estimated from the intersection with the x-axis of the linear extrapolation of the last points of the I-V curve:<disp-formula id="equ1">
<mml:math id="m1">
<mml:mrow>
<mml:msub>
<mml:mi mathvariant="normal">G</mml:mi>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mi mathvariant="normal">V</mml:mi>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:msub>
<mml:mo>&#x3d;</mml:mo>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:msub>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mrow>
<mml:mtext>peak</mml:mtext>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mi mathvariant="normal">V</mml:mi>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mo>/</mml:mo>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">V</mml:mi>
<mml:mo>&#x2212;</mml:mo>
</mml:mrow>
<mml:msub>
<mml:mi mathvariant="normal">V</mml:mi>
<mml:mtext>Rev</mml:mtext>
</mml:msub>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
</mml:math>
</disp-formula>
</p>
<p>The voltage-dependent activation parameters were obtained by fitting a single Boltzmann function to the normalized conductance (G<sub>(V)</sub>/G<sub>max</sub>):<disp-formula id="equ2">
<mml:math id="m2">
<mml:mrow>
<mml:mfrac bevelled="true">
<mml:mrow>
<mml:msub>
<mml:mi mathvariant="italic">G</mml:mi>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mi mathvariant="italic">V</mml:mi>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi mathvariant="italic">G</mml:mi>
<mml:mi mathvariant="italic">max</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfrac>
<mml:mo>&#x3d;</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>/</mml:mo>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>&#x2b;</mml:mo>
<mml:mi>e</mml:mi>
</mml:mrow>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:msub>
<mml:mi>V</mml:mi>
<mml:mrow>
<mml:mn>0.5</mml:mn>
<mml:mi>a</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>V</mml:mi>
<mml:mi>m</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>/</mml:mo>
<mml:msub>
<mml:mi>k</mml:mi>
<mml:mrow>
<mml:mi>a</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
</mml:math>
</disp-formula>
</p>
<p>Initial values for the fitting routine (GraphPad Prism) were <italic>G</italic> <sub>
<italic>max</italic>
</sub> &#x3d; 0.01, V<sub>Rev</sub> &#x3d; 30&#xa0;mV, <italic>V</italic>
<sub>
<italic>0.5act</italic>
</sub> &#x3d; &#x2212;50&#xa0;mV and <italic>k</italic>
<sub>
<italic>act</italic>
</sub> &#x3d; 5&#xa0;mV.</p>
<p>Time constants (&#x3c4;) for activation (&#x3c4;<sub>Act</sub>) and inactivation (&#x3c4;<sub>Inact</sub>) kinetics were obtained using a double-exponential fit of the current traces:<disp-formula id="equ3">
<mml:math id="m3">
<mml:mrow>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mo>&#x3d;</mml:mo>
<mml:msub>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mi>max</mml:mi>
</mml:msub>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mo>&#x2a;</mml:mo>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>&#x2212;</mml:mo>
<mml:mi>exp</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mo>&#x2013;</mml:mo>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mo>/</mml:mo>
<mml:mtext>&#x2009;</mml:mtext>
<mml:msub>
<mml:mi mathvariant="normal">&#x3c4;</mml:mi>
<mml:mtext>Act</mml:mtext>
</mml:msub>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mo>&#x2a;</mml:mo>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mo>&#x2061;</mml:mo>
<mml:mi>exp</mml:mi>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mo>&#x2013;</mml:mo>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mo>/</mml:mo>
<mml:mtext>&#x2009;</mml:mtext>
<mml:msub>
<mml:mi mathvariant="normal">&#x3c4;</mml:mi>
<mml:mtext>Inact</mml:mtext>
</mml:msub>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#x2b;</mml:mo>
<mml:msub>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mi>min</mml:mi>
</mml:msub>
</mml:mrow>
</mml:math>
</disp-formula>
</p>
<p>The voltage-dependent activation parameters were obtained by fitting a single Boltzmann function with initial values: <italic>V</italic>
<sub>
<italic>0.5inact</italic>
</sub> &#x3d; &#x2212;70&#xa0;mV, <italic>k</italic>
<sub>
<italic>inact</italic>
</sub> &#x3d; 5&#xa0;mV:<disp-formula id="equ4">
<mml:math id="m4">
<mml:mrow>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mo>/</mml:mo>
<mml:msub>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mi>max</mml:mi>
</mml:msub>
<mml:mo>&#x3d;</mml:mo>
<mml:mn>1</mml:mn>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mo>/</mml:mo>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>&#x2b;</mml:mo>
<mml:mi>exp</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">V</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
</mml:mrow>
<mml:mo>&#x2013;</mml:mo>
<mml:mtext>&#x2009;</mml:mtext>
<mml:msub>
<mml:mi>V</mml:mi>
<mml:mrow>
<mml:mn>0.5</mml:mn>
<mml:mi>i</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mo>/</mml:mo>
<mml:mtext>&#x2009;</mml:mtext>
<mml:msub>
<mml:mi>k</mml:mi>
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
</mml:math>
</disp-formula>
</p>
<p>The following quality control criteria were applied for APC recordings. Only cells with Rseal &#x3e;300 MOhm, RSeries &#x3c;18 MOhm and Ileak &#x3e;&#x2212;200&#xa0;pA for at least 75% of the recorded sweeps within the protocol have been kept for the analyses. For activation-related protocols, were excluded cells with a slope of activation &#x3c;2&#xa0;mV or &#x3e;9.5&#xa0;mV. Similarly for inactivation-related protocols, were excluded cells with a slope of inactivation &#x3c;&#x2212;12&#xa0;mV or &#x3e;&#x2212;2&#xa0;mV.</p>
</sec>
<sec id="s2-6">
<title>Neuronal <italic>in silico</italic> modeling</title>
<p>Modeling was performed using the NEURON simulation environment (<xref ref-type="bibr" rid="B13">Hines and Carnevale, 1997</xref>). The model of cerebellar nuclear neuron is based on a previously published model (<xref ref-type="bibr" rid="B30">Sudhakar et al., 2015</xref>), downloaded from the NEURON database at Yale University (<ext-link ext-link-type="uri" xlink:href="https://modeldb.science/185513">https://modeldb.science/185513</ext-link>). Neuronal activities were generated using the medium value of input gain, as described previously (<xref ref-type="bibr" rid="B30">Sudhakar et al., 2015</xref>). The electrophysiological properties of the Ca<sub>v</sub>3.1 channels were modeled using Hodgkin-Huxley equations as described previously. The values obtained for the Ca<sub>v</sub>3.1 WT and the variant channels were substituted for the corresponding values of native T-type channels in cerebellar nuclear neurons after fitting them with the initial model values in GraphPad Prism (see equations below). The membrane voltage values were corrected for liquid junction potential, which was 4.5&#xa0;mV in the recording conditions.<disp-formula id="equ5">
<mml:math id="m5">
<mml:mrow>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">v</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi mathvariant="normal">s</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">d</mml:mi>
<mml:mi mathvariant="normal">y</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi mathvariant="normal">s</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mtext>minf</mml:mtext>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#x3d;</mml:mo>
<mml:mn>1.0</mml:mn>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mo>/</mml:mo>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>&#x2b;</mml:mo>
<mml:mi>exp</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">v</mml:mi>
<mml:mo>&#x2212;</mml:mo>
</mml:mrow>
<mml:msub>
<mml:mi mathvariant="normal">v</mml:mi>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>/</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>_</mml:mo>
<mml:mtext>minf</mml:mtext>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mrow>
<mml:mo>/</mml:mo>
</mml:mrow>
<mml:mi mathvariant="normal">k</mml:mi>
<mml:mo>_</mml:mo>
<mml:mtext>minf</mml:mtext>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
</mml:math>
</disp-formula>
<disp-formula id="equ6">
<mml:math id="m6">
<mml:mrow>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">v</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi mathvariant="normal">s</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">d</mml:mi>
<mml:mi mathvariant="normal">y</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi mathvariant="normal">s</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mtext>hinf</mml:mtext>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#x3d;</mml:mo>
<mml:mn>1.0</mml:mn>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mo>/</mml:mo>
</mml:mrow>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mo>(</mml:mo>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>&#x2b;</mml:mo>
<mml:mi>exp</mml:mi>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">v</mml:mi>
<mml:mo>&#x2212;</mml:mo>
</mml:mrow>
<mml:msub>
<mml:mi mathvariant="normal">v</mml:mi>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mrow>
<mml:mo>/</mml:mo>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>_</mml:mo>
<mml:mtext>hinf</mml:mtext>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mrow>
<mml:mo>/</mml:mo>
<mml:mi mathvariant="normal">k</mml:mi>
<mml:mo>_</mml:mo>
<mml:mtext>hinf</mml:mtext>
</mml:mrow>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:math>
</disp-formula>
<disp-formula id="equ7">
<mml:math id="m7">
<mml:mrow>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">v</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi mathvariant="normal">k</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">s</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mtext>taum</mml:mtext>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#x3d;</mml:mo>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mi mathvariant="normal">C</mml:mi>
<mml:mo>_</mml:mo>
<mml:mtext>taum</mml:mtext>
<mml:mo>&#x2b;</mml:mo>
<mml:mn>0.333</mml:mn>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mo>/</mml:mo>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mo>&#x2061;</mml:mo>
<mml:mi>exp</mml:mi>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">v</mml:mi>
<mml:mo>&#x2212;</mml:mo>
</mml:mrow>
<mml:msub>
<mml:mi mathvariant="normal">v</mml:mi>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>/</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>_</mml:mo>
<mml:mrow>
<mml:mtext>taum</mml:mtext>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>/</mml:mo>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi mathvariant="normal">k</mml:mi>
<mml:mo>_</mml:mo>
<mml:mrow>
<mml:mtext>taum</mml:mtext>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#x2b;</mml:mo>
<mml:mi>exp</mml:mi>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">v</mml:mi>
<mml:mo>&#x2212;</mml:mo>
</mml:mrow>
<mml:msub>
<mml:mi mathvariant="normal">v</mml:mi>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>/</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>_</mml:mo>
<mml:mtext>tau</mml:mtext>
<mml:mo>_</mml:mo>
<mml:mrow>
<mml:mi mathvariant="normal">m</mml:mi>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>/</mml:mo>
<mml:mi mathvariant="normal">k</mml:mi>
<mml:mo>_</mml:mo>
<mml:mrow>
<mml:mtext>taum</mml:mtext>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
</mml:math>
</disp-formula>
<disp-formula id="equ8">
<mml:math id="m8">
<mml:mrow>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">v</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi mathvariant="normal">k</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">s</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mtext>tauh</mml:mtext>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#x3d;</mml:mo>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mi mathvariant="normal">C</mml:mi>
<mml:mo>_</mml:mo>
<mml:mtext>tauh</mml:mtext>
<mml:mo>&#x2b;</mml:mo>
<mml:mn>0.333</mml:mn>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mo>/</mml:mo>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>exp</mml:mi>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">v</mml:mi>
<mml:mo>&#x2212;</mml:mo>
</mml:mrow>
<mml:msub>
<mml:mi mathvariant="normal">v</mml:mi>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>/</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>_</mml:mo>
<mml:mrow>
<mml:mtext>tauh</mml:mtext>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>/</mml:mo>
<mml:mi mathvariant="normal">k</mml:mi>
<mml:mo>_</mml:mo>
<mml:mrow>
<mml:mtext>tauh</mml:mtext>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
</mml:math>
</disp-formula>
</p>
</sec>
<sec id="s2-7">
<title>Statistical analyses</title>
<p>Data were analyzed with GraphPad Prism and results are presented as means &#xb1; standard error of the mean (SEM). P-values for the statistical analyses were calculated using nonparametric (Kruskal&#x2013;Wallis) one-way ANOVA followed by Dunnett&#x2019;s <italic>post hoc</italic> multiple comparison test with the following significance criteria &#x2a;<italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01, and &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Current density measurements in APC</title>
<p>The 18 Ca<sub>v</sub>3.1 variants that we transiently transfected for electrophysiological characterization using APC are presented in <xref ref-type="table" rid="T1">Table 1</xref> and in <xref ref-type="fig" rid="F1">Figure 1</xref>. Eight variants were here investigated for the first time in electrophysiological studies: p.R102Q, p.V184G, p.N1200S, p.S1263A, p.R1718G, p.R1813W, p.V1835M, and p.D2242N. Among these, the p.S1263A and p.R1718G variants were recently reported (<xref ref-type="bibr" rid="B29">Riquet et al., 2023</xref>; <xref ref-type="bibr" rid="B27">Qebibo et al., 2024</xref>) but uncharacterized at the functional level. The six other variants were identified by the genetic diagnostic centers involved in this study. They had not previously been reported and were annotated as variants of uncertain significance (VUS). Calcium currents were recorded using MPC for 10 of these variants, p.M197R, p.L208P, p.V392M, p.F956del, p.A961T, p.I962N, p.I1412T, p.M1531V, p.G1534D, and p.R1715H in recent studies (<xref ref-type="bibr" rid="B8">Coutelier et al., 2015</xref>; <xref ref-type="bibr" rid="B7">Chemin et al., 2018</xref>; <xref ref-type="bibr" rid="B3">Berecki et al., 2020</xref>; <xref ref-type="bibr" rid="B27">Qebibo et al., 2024</xref>). Variants located on the S4 segments are shown in green, those on the S5 segments in blue, the S6 segments in red, and those on the loops in grey (<xref ref-type="fig" rid="F1">Figure 1A</xref>) with 15 of them being mapped onto the cryo-EM structure of the Cav3.1 protein (<xref ref-type="fig" rid="F1">Figure 1B</xref>; (<xref ref-type="bibr" rid="B35">Zhao et al., 2019</xref>)). In APC experiments, the percentage of Ca<sub>v</sub>3.1 current-positive cells was in the range of 75% (comparing Ca<sub>v</sub>3.1 WT transfected cells with mock transfected cells). Only cells with a current density greater than 5pA/pF were considered for further calcium current analyses. This approach led us identify 6 variants (p.M197R, p.V392M, p.F956del, p.I962N, p.I1412T, and p.G1534D) with current densities significantly lower than Ca<sub>v</sub>3.1 WT channels (<xref ref-type="fig" rid="F2">Figure 2A</xref>; <xref ref-type="sec" rid="s12">Supplementary Table S1</xref>; <xref ref-type="sec" rid="s12">Supplementary Figures S1&#x2013;S8</xref>). Four of these variants, p.M197R, p.F956del, p.I1412T, and p.G1534D, previously characterized using MPC (<xref ref-type="bibr" rid="B27">Qebibo et al., 2024</xref>), exhibited too few cells with sufficiently large enough calcium current density for accurate biophysical characterization in APC experiments. These 4 variants, along with p.V392M, for which only half-activation potentials could be determined, were excluded from further analysis of their APC recordings. Only the p.I962N variant exhibited a sufficiently high average current density and quality current traces for complete APC-based characterization. Contrasting with low expressing variants, p.V184G, p.N1200S, p.S1263A and p.D2242N variants displayed significantly higher current densities (<xref ref-type="fig" rid="F2">Figure 2A</xref>). The superimposed representative current traces at &#x2212;20 mV (<xref ref-type="fig" rid="F2">Figures 2B&#x2013;E</xref>) illustrate the difference in current density across all these variants, especially those with near-null current density (p.M197R and p.I1412T). In addition, these current traces revealed the pronounced differences in inactivation kinetics, which appeared markedly slowed for the variants located on the S5 and S6 segments defining the IG (<xref ref-type="fig" rid="F2">Figures 2C,D</xref>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Presentation of the 18 <italic>CACNA1G</italic> variants investigated in the study in automated patch-clamp (APC), manual patch-clamp (MPC) or both (APC/MPC). The clinical description of the variants in black can be found in previous studies (see references).</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Variants</th>
<th align="center">MPC/APC tested</th>
<th align="center">Inheritance</th>
<th align="center">Clinical information</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">
<bold>p.R102Q</bold>
</td>
<td align="center">APC</td>
<td align="center">
<italic>not known</italic>
</td>
<td align="left">Ataxia, progressive cerebellar atrophy, global developmental delay. Medical history complicated by prenatal exposures to drugs/alcohol. Possible encephalitis in infancy. Variant also present in EXAC.</td>
</tr>
<tr>
<td align="left">
<bold>p.V184G</bold>
</td>
<td align="center">APC</td>
<td align="center">
<italic>not known</italic>
</td>
<td align="left">Adult-onset neuromuscular disease, including ptosis, muscle weakness, peripheral neuropathy, and ataxia</td>
</tr>
<tr>
<td align="left">p.M197R</td>
<td align="center">APC/<bold>
<underline>MPC</underline>
</bold>
</td>
<td align="center">
<italic>de novo</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B27">Qebibo et al. (2024)</xref>
</td>
</tr>
<tr>
<td align="left">p.L208P</td>
<td align="center">APC</td>
<td align="center">
<italic>de novo</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B3">Berecki et al. (2020)</xref>
</td>
</tr>
<tr>
<td align="left">p.V392M</td>
<td align="center">APC/MPC</td>
<td align="center">
<italic>de novo</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B27">Qebibo et al. (2024)</xref>
</td>
</tr>
<tr>
<td align="left">p.F956del</td>
<td align="center">APC/<bold>
<underline>MPC</underline>
</bold>
</td>
<td align="center">
<italic>de novo</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B27">Qebibo et al. (2024)</xref>
</td>
</tr>
<tr>
<td align="left">p.A961T</td>
<td align="center">APC/MPC</td>
<td align="center">
<italic>de novo</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B7">Chemin et al. (2018),</xref> <xref ref-type="bibr" rid="B27">Qebibo et al. (2024)</xref>
</td>
</tr>
<tr>
<td align="left">p.I962N</td>
<td align="center">APC/MPC</td>
<td align="center">
<italic>de novo</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B27">Qebibo et al. (2024)</xref>
</td>
</tr>
<tr>
<td align="left">
<bold>p.N1200S</bold>
</td>
<td align="center">APC/MPC</td>
<td align="center">
<italic>de novo</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B16">Kosmicki et al. (2017)</xref>
</td>
</tr>
<tr>
<td align="left">p.S1263A</td>
<td align="center">APC</td>
<td align="center">
<italic>de novo</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B27">Qebibo et al. (2024)</xref>
</td>
</tr>
<tr>
<td align="left">p.I1412T</td>
<td align="center">APC/<bold>
<underline>MPC</underline>
</bold>
</td>
<td align="center">
<italic>de novo</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B27">Qebibo et al. (2024)</xref>
</td>
</tr>
<tr>
<td align="left">p.M1531V</td>
<td align="center">APC/MPC</td>
<td align="center">
<italic>de novo</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B7">Chemin et al. (2018),</xref> <xref ref-type="bibr" rid="B27">Qebibo et al. (2024)</xref>
</td>
</tr>
<tr>
<td align="left">p.G1534D</td>
<td align="center">APC/<bold>
<underline>MPC</underline>
</bold>
</td>
<td align="center">
<italic>de novo</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B27">Qebibo et al. (2024)</xref>
</td>
</tr>
<tr>
<td align="left">p.R1715H</td>
<td align="center">APC/MPC</td>
<td align="center">inherited</td>
<td align="left">
<xref ref-type="bibr" rid="B8">Coutelier et al. (2015)</xref>
</td>
</tr>
<tr>
<td align="left">p.R1718G</td>
<td align="center">APC</td>
<td align="center">
<italic>de novo</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B29">Riquet et al. (2023),</xref> <xref ref-type="bibr" rid="B27">Qebibo et al. (2024)</xref>
</td>
</tr>
<tr>
<td align="left">
<bold>p.R1813W</bold>
</td>
<td align="center">APC</td>
<td align="left"/>
<td align="left">Congenital ataxia. Found in one patient, inherited from his mother, both also having a known pathogenic <italic>CACNA1A</italic> variant but with incomplete penetrance/expressivity</td>
</tr>
<tr>
<td align="left">
<bold>p.V1835M</bold>
</td>
<td align="center">APC/MPC</td>
<td align="center">inherited</td>
<td align="left">A 2.5-year-old girl (in 2019) with developmental delay, microcephaly, and tremor (when scared/anxious). Exome sequencing revealed a pathogenic variant in <italic>MECP2</italic>, so she has Rett syndrome. She also has tremor. Her brain MRI at 1.5 years was normal; it did not show cerebellar atrophy</td>
</tr>
<tr>
<td align="left">
<bold>p.D2242N</bold>
</td>
<td align="center">APC</td>
<td align="center">
<italic>not known</italic>
</td>
<td align="left">Mild intellectual disability, ophthalmoplegia, and progressive ataxia, dysarthria, and dysphagia. He has developed prognathism. Brain MRI shows olivopontocerebellar atrophy</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>The variants in bold-red are reported for the first time, with a brief clinical description of the related patients. Bold-underlined MPC indicates that the properties of these variants were preferentially obtained in MPC.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Schematic localization on the Cav3.1 channel of the 18 variants investigated in this study. <bold>(A)</bold> The transmembrane topology of the Cav3.1 calcium channel shows the four domains repeat (DI to DIV), each composed of six transmembrane segments (S1 to S6). Variants on segments S4, S5, S6, and the intracellular and extracellular loops (IC, EC) are depicted in green, blue, red, and gray, respectively. <bold>(B)</bold> 3D representation of the position of 15 variants on the Cryo-EM resolved structure of Cav3.1 (PDB: 6KZO (<xref ref-type="bibr" rid="B35">Zhao et al., 2019</xref>) with a side view (left panel) and a bottom view (right panel). The 3 additional variants (p.N1200S, p.S1263A and p.D2242N) are found in area of the Cav3.1 protein that were not resolved in the 6KZO PDB structure.</p>
</caption>
<graphic xlink:href="fphar-16-1613072-g001.tif">
<alt-text content-type="machine-generated">Diagram showing a protein structure with labeled segments and mutations. Image A illustrates a 2D schematic with green, magenta, red, and cyan circles indicating S4, S5, S6 segments, and IC &#x26; EC loops, respectively. Mutations are marked with varying colors and labels. Image B shows 3D protein structures with relevant segments in corresponding colors from two perspectives, including a 90-degree rotation. Red, green, and other colored spheres represent mutation sites.</alt-text>
</graphic>
</fig>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Density and calcium current traces for the 18 Cav3.1 variants studies in APC. <bold>(A)</bold> Graph of the calcium current density at &#x2212;30&#xa0;mV for all the variants, normalized to the WT current density. The red dotted line indicates the maximum density obtained on empty pcDNA3-transfected cells (&#x223c;5pA/pF) that was used to identify low-expressing cells excluded for further biophysical analysis. <bold>(B,E)</bold> Current trace examples at &#x2212;30&#xa0;mV for the all the variants grouped according to their localization in the Cav3.1 protein. Distinct colors were used to better visualize the calcium current traces illustrating each variant of the S4 group [in green, <bold>(B)</bold>] the S5 group [in blue, <bold>(C)</bold>] the S6 group [in red, <bold>(D)</bold>] and the group comprising variants in loops, N-ter and C-ter [in grey, <bold>(E)</bold>] compared to WT (black dotted line).</p>
</caption>
<graphic xlink:href="fphar-16-1613072-g002.tif">
<alt-text content-type="machine-generated">Bar and line graphs showing the effects of various mutants on normalized density and current response. A) Bar graph of normalized density for different mutants, with significant differences marked by asterisks. B-E) Line graphs displaying current responses of S4, S5, S6, and ICL &#x26; ECL mutants compared to wild type. Each graph includes a legend identifying colors for different mutants and axes indicating current (pA) and time (ms).</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-2">
<title>Biophysical properties of variants characterized by APC</title>
<p>The activation kinetics is rather fast for the WT Ca<sub>v</sub>3.1 current (&#x223c;4&#xa0;ms at &#x2212;20 mV) in APC recordings. The S4 variants p.R1715H and p.R1718G, as well as the S6 variant p.V1835M, exhibit slower activation, while most of the variants in S5 and S6 segments display faster activation (<xref ref-type="fig" rid="F3">Figure 3A</xref>; <xref ref-type="sec" rid="s12">Supplementary Figure S1</xref>; <xref ref-type="sec" rid="s12">Supplementary Table S1</xref>), compared to WT. Similar to findings reported using MPC, the inactivation and deactivation kinetics are significantly slower for the S5 and S6 IG variants (p.L208P, p.A961T, p.I962N, p.M1531V) (<xref ref-type="fig" rid="F3">Figures 3B,C</xref>; <xref ref-type="sec" rid="s12">Supplementary Figures S2, S3</xref>; <xref ref-type="sec" rid="s12">Supplementary Table S1</xref>). Regarding recovery from inactivation, the p.L208P, p.A961T, and p.I962N variants exhibit the slowest recovery rates and do not fully recover from inactivation (<xref ref-type="fig" rid="F3">Figure 3D</xref>; <xref ref-type="sec" rid="s12">Supplementary Figure S4</xref>; <xref ref-type="sec" rid="s12">Supplementary Table S1</xref>), again in good agreement with MPC experiments. Examples of current traces illustrating APC recordings of deactivation kinetics and recovery from inactivation are provided for WT and p.A961T variant (<xref ref-type="fig" rid="F3">Figures 3E,F</xref>). Notably, all the variants evaluated in APC experiments display no shift or a negative shift in their steady-state activation and inactivation properties (<xref ref-type="fig" rid="F4">Figures 4A,B</xref>; <xref ref-type="sec" rid="s12">Supplementary Table S1</xref>). Consistent with MPC experiments, these hyperpolarizing shifts were highly significant for the IG variants p.L208P, p.V392M, p.A961T, p.I962N and p.M1531V.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Kinetic properties of Cav3.1 variants using APC. <bold>(A)</bold> Activation kinetics at &#x2212;20&#xa0;mV. <bold>(B)</bold> Inactivation kinetics at &#x2212;20&#xa0;mV. <bold>(C)</bold> Deactivation kinetics at &#x2212;60&#xa0;mV. <bold>(D)</bold> Recovery from inactivation. <bold>(E)</bold> Examples of APC recordings of deactivation kinetics for WT (black) and p.A961T (red) with bold traces corresponding to the repolarization step at &#x2212;60&#xa0;mV. <bold>(F)</bold> Examples of APC recordings of the recovery from inactivation for WT (black) and p.A961T (red). Both in the upper and lower graphs, the large dotted lines at the bottom correspond to P1 amplitude and every P2 amplitude is marked with a short dotted line (black for WT and red for p.A961T). Note that the recordings for the variants p.M197R, p.V392M, p.F956del, p.I1412T and p.G1534D did not meet quality controls for measuring all the electrophysiological parameters. Variants on segments S4, S5, S6, and IC and EC loops are represented in green, blue, red, and gray, respectively.</p>
</caption>
<graphic xlink:href="fphar-16-1613072-g003.tif">
<alt-text content-type="machine-generated">Bar charts (A-D) illustrate the time constants for activation, inactivation, deactivation, and recovery of various mutations compared to the wild type. Traces (E-F) show electrophysiological recordings, with wild type (WT) depicted in black and mutant A961T in red, highlighting differences in current amplitude and time courses.</alt-text>
</graphic>
</fig>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Half-activation and inactivation properties of Cav3.1 variants using APC. <bold>(A)</bold> The shift in steady-state half-activation potential (V<sub>1/2</sub> activation) for each variant is compared to the WT value. <bold>(B)</bold> The shift in steady-state half-inactivation potential (V<sub>1/2</sub> inactivation) for each variant is compared to the WT value. Variants on segments S4, S5, S6, and IC and EC loops are represented in green, blue, red, and gray, respectively.</p>
</caption>
<graphic xlink:href="fphar-16-1613072-g004.tif">
<alt-text content-type="machine-generated">Bar charts showing V&#x2081;/&#x2082; activation and inactivation shifts in millivolts for various mutations compared to wild-type (WT). Panel A shows activation shifts, with some bars significantly shifted, indicated by asterisks. Panel B shows inactivation shifts, also with significant variations. Mutations like R102Q and V184G are noted alongside sample sizes in parentheses. Bars are color-coded, with some highlighted in red, blue, and green, and include error bars.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-3">
<title>Correlation between APC and MPC data</title>
<p>Superimposed current-voltage relationships (<xref ref-type="fig" rid="F5">Figure 5A</xref>), steady-state activation (<xref ref-type="fig" rid="F5">Figure 5B</xref>) and steady-state inactivation (<xref ref-type="fig" rid="F5">Figure 5C</xref>) recorded in MPC and APC for the WT and the most recurrent SCA42ND variant (p.A961T) clearly illustrate that the hyperpolarizing shift in steady-state properties for the p.A961T variant was comparable in MPC and APC experiments. The use of a higher extracellular calcium concentration in APC (5.2&#xa0;mM), compared to MPC (2&#xa0;mM), resulted in a depolarizing shift of similar amplitude for both the WT and p.A961T variant in steady-state activation (15&#xa0;mV for WT and 16&#xa0;mV for p.A961T) and in steady-state inactivation (4&#xa0;mV for WT and 3&#xa0;mV for p.A961T). We then assessed the correlation between the electrophysiological properties measured in APC and MPC for the set of variants studied in both experiments (<xref ref-type="fig" rid="F5">Figures 5D&#x2013;G</xref>). Indeed, both steady-state activation (V<sub>1/2act</sub>) and steady-state inactivation (V<sub>1/2inact</sub>) showed a robust correlation (r close to 1, p &#x3c; 0.05) between APC and MPC (<xref ref-type="fig" rid="F5">Figures 5D,E</xref>), as well as for deactivation kinetics and recovery from inactivation (<xref ref-type="fig" rid="F5">Figure 5G</xref>; <xref ref-type="sec" rid="s12">Supplementary Figure S5</xref>). However, no correlation was observed for inactivation kinetics data (r &#x3d; 0.66), likely due to the dispersion of values for slow-inactivating variants, compared to the highly clustered WT-like variants (<xref ref-type="fig" rid="F5">Figure 5F</xref>). A lack of correlation was also observed for the activation kinetics (<xref ref-type="sec" rid="s12">Supplementary Figure S5</xref>).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Comparison of MPC and APC electrophysiological parameters. <bold>(A)</bold> I-V curves obtained using MPC (open symbols) and APC (filled symbols) for WT (black) and the recurrent SCA42ND variant p.A961T (red). <bold>(B)</bold> Steady-state activation curves. <bold>(C)</bold> Steady-state inactivation curves. <bold>(D&#x2013;G)</bold> The correlation graphs for half-activation potential <bold>(D)</bold> half-inactivation potential <bold>(E)</bold> inactivation kinetics <bold>(F)</bold> and deactivation kinetics <bold>(G)</bold> respectively, measured in APC (X axis) and MPC (Y axis). Variants on segments S4, S5, S6, and IC and EC loops are represented in green, blue, red, and gray, respectively.</p>
</caption>
<graphic xlink:href="fphar-16-1613072-g005.tif">
<alt-text content-type="machine-generated">Graphs labeled A to G show various electrophysiological properties. A displays current-voltage relationships with legend indicating wild-type (WT) and A961T variants. B and C illustrate conductance and normalized current in relation to voltage, respectively. D to G present scatter plots showing relationships between APC and MPC conditions for activation and inactivation kinetics, with specific mutations labeled. Correlation coefficients and significance values are included in some graphs.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-4">
<title>Predicted consequence of Ca<sub>v</sub>3.1 variants properties on neuronal excitability</title>
<p>The electrophysiological parameters collected in MPC and APC experiments (V<sub>1/2</sub> act, V<sub>1/2</sub> inact, Kact, Kinact, Tau act, Tau inact, Tau deact) were used in a virtual model of DCN neurons (<xref ref-type="bibr" rid="B30">Sudhakar et al., 2015</xref>) to estimate the effects of the variants on DCN firing activity by measuring the action potential (AP) frequency (<xref ref-type="fig" rid="F6">Figure 6</xref>; <xref ref-type="sec" rid="s12">Supplementary Figures S6-S8</xref>). We recently reported that the IG variants investigated in MPC (p.V392M, p.F956del, p.A961T, p.I962N, p.I1412T, p.M1531V, p.G1534D) produced a higher AP frequency compared to WT (<xref ref-type="bibr" rid="B27">Qebibo et al., 2024</xref>). Notably, using the parameters of the variants fully explored with the APC approach, the p.A961T, p.I962N and p.M1531V variants, and to a lesser extent the p.L208P variant, also showed a higher AP frequency (<xref ref-type="fig" rid="F6">Figure 6A</xref>) as exemplified for p.A961T compared to WT (<xref ref-type="fig" rid="F6">Figures 6B,C</xref>). Since APC experiments revealed that Ca<sub>v</sub>3.1 variants exhibit either increased or decreased current density compared to WT channel (<xref ref-type="fig" rid="F2">Figure 2A</xref>), we next investigated the impact of varying current density on AP frequency for all the variants studied in APC (<xref ref-type="fig" rid="F6">Figure 6D</xref>) and those studied in MPC (<xref ref-type="fig" rid="F6">Figure 6E</xref>). A 2-fold increase in current density resulted in a marked AP-frequency increase for GOF variants, especially p.L208P (<xref ref-type="fig" rid="F6">Figure 6D</xref>). WT-like variants also displayed increased AP-frequency, while no change was observed for the loss-of-channel-activity variant p.M197R (<xref ref-type="fig" rid="F6">Figure 6E</xref>). Finally, when DCN modeling was performed using the Ca<sub>v</sub>3.1 current density measured in APC (see <xref ref-type="fig" rid="F2">Figure 2A</xref>), only the IG variants p.M1531V &#x3e; p.A961T &#x3e; p.L208P &#x3e; p.I962N, as well as the variants p.V184G and p.N1200S showed increased AP-frequency (<xref ref-type="fig" rid="F6">Figures 6F,G</xref>; <xref ref-type="sec" rid="s12">Supplementary Figures S7-S8</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Deep Cerebellar Nucleus (DCN) modeling using Cav3.1 variant parameters obtained in APC and in MPC experiments. <bold>(A)</bold> Spike frequency graph for Cav3.1 variants characterized using APC. <bold>(B,C)</bold> Examples of DCN spiking activity for using APC parameters obtained for WT <bold>(B)</bold> and p.A961T channels <bold>(C)</bold>. <bold>(D,E)</bold> Change in DCN spike frequency obtained with increasing current densities for all the variants characterized in APC <bold>(D)</bold> and in MPC <bold>(E)</bold> respectively. <bold>(F,G)</bold> The DCN spike frequency obtained for the current density measured in <xref ref-type="fig" rid="F2">Figure 2B</xref> (normalized to the WT current density) for the variants characterized in APC <bold>(F)</bold> and MPC <bold>(G)</bold> respectively.</p>
</caption>
<graphic xlink:href="fphar-16-1613072-g006.tif">
<alt-text content-type="machine-generated">Panel of graphs illustrating frequency, time, and density data for different mutations. Panel A shows a bar graph with frequency data for various APC mutations. Panel B is a line graph of membrane potential over time for WT (APC). Panel C shows a similar graph for A961T (APC) mutation. Panel D depicts a line graph of frequency versus density for multiple APC mutations. Panel E presents frequency versus density for MPC mutations. Panel F is a bar graph of frequency data for APC mutations, and Panel G shows similar data for MPC mutations. Each mutation is color-coded across panels.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-5">
<title>GOF properties in action-potential clamp experiments for p.M1531V and p.A961T</title>
<p>A further functional evaluation of the GOF properties of four representative IG variants (p.V392M, p.A961T, p.M1531V, p.G1534D) was performed using action potential (AP) clamp experiments in MPC (<xref ref-type="fig" rid="F7">Figure 7</xref>). Calcium currents were recorded in HEK-293 cells expressing these variants during an AP-voltage command, mimicking (i) a tonic firing activity of Purkinje cells and (ii) a rebound burst firing from thalamic nRT neurons. In these recordings, the resulting calcium current reflects the specific electrophysiological behavior of each variant (<xref ref-type="fig" rid="F7">Figures 7A,B</xref>). For tonic firing activity, it is noteworthy that most of the inward current occurred during the interspike interval, linked to the slow deactivation of Ca<sub>v</sub>3.1, which was even slower for IG variants (<xref ref-type="fig" rid="F7">Figure 7A</xref>). For rebound burst firing activity, the calcium current relies on both Ca<sub>v</sub>3.1 de-inactivation and slow deactivation (<xref ref-type="fig" rid="F7">Figure 7B</xref>). The area under the curve (AUC) was measured and normalized to the maximum amplitude of the current density recorded in each cell using a standard test-pulse protocol. The p.A961T and p.M1531V variants exhibited a significant increase in calcium current during both tonic and rebound burst activities (<xref ref-type="fig" rid="F7">Figures 7C,D</xref>). Conversely, the p.V392M and p.G1534D variants showed reduced calcium current during tonic firing activity (<xref ref-type="fig" rid="F7">Figure 7C</xref>). During rebound burst activity, the p.G1534D variant exhibited a moderate increase in calcium current, whereas the p.V392M variant showed lower calcium entry, compared to WT (<xref ref-type="fig" rid="F7">Figure 7D</xref>). AP waveform rebound burst model confirms slowed deactivation of all the variants and shows an increased activity at step to hyperpolarizing voltages for variants with GOF features (A961T and M1531V) but not for variants with mix GoF and LoF features (e.g., V392M and G1534D). These AP clamp experiments highlight that the Ca<sub>v</sub>3.1 variant-dependent calcium entry is influenced by the neurons&#x2019; electrophysiological behavior and further confirm the GOF properties of the p.A961T and p.M1531V variants.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Action-potential clamp experiments with IG variants. <bold>(A)</bold> Representative calcium current traces, normalized to the 1st AP, for p.A961T, p.M1531V, p.V392M, and p.G1534D variants (lower panel) in response to a Purkinje cell tonic firing activity used as voltage command (upper panel). <bold>(B)</bold> Representative calcium current traces, normalized to the 1st AP, for p.A961T, p.M1531V, p.V392M, and p.G1534D variants (lower panel) in response to a thalamic rebound burst firing activity used as voltage command (upper panel). <bold>(C,D)</bold> The integral (area under the curve) quantification of the calcium current for each variant obtained for the tonic firing activity <bold>(C)</bold> and the rebound burst activity <bold>(D)</bold> respectively. The histograms of the average AUC values at 800&#xa0;ms (endpoint of the recordings) are shown as insets in panels 7C and 7D.</p>
</caption>
<graphic xlink:href="fphar-16-1613072-g007.tif">
<alt-text content-type="machine-generated">Panel A shows tonic firing traces in neurons with different genetic variants: A961T, M1531V, V392M, and G1534D. Panel B displays rebound burst firing with detailed traces for the same variants, highlighting differences. Panel C is a graph showing the area under the curve (AUC) over time for each mutation, with A961T and M1531V having higher AUC. Panel D illustrates a similar AUC graph at a different time scale, providing comparative data among variants. Insets in panels C and D show bar graphs summarizing AUC values at specific times.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<sec id="s4-1">
<title>Automated patch-clamp techniques for classification of Cav3 channelopathies</title>
<p>The APC technology is revolutionizing the field of electrophysiology, including for the study of channelopathies, by allowing investigation of a large number of variants associated with various neurological and cardiac disorders (<xref ref-type="bibr" rid="B31">Vanoye et al., 2021</xref>). APC allows to record and analyze hundreds of cells in parallel, providing a more comprehensive characterization of ion channel variants (<xref ref-type="bibr" rid="B23">Ng et al., 2021</xref>; <xref ref-type="bibr" rid="B20">Ma et al., 2023</xref>). Traditional MPC techniques are highly accurate in describing parameters, but time-consuming and labor-intensive, whereas APC offers high-throughput capability and may be less operator-dependent (<xref ref-type="bibr" rid="B33">Yajuan et al., 2012</xref>). This is particularly crucial given the growing number of identified ion channel variants (<xref ref-type="bibr" rid="B19">Lukacs et al., 2021</xref>; <xref ref-type="bibr" rid="B24">Obergrussberger et al., 2022</xref>) as evidenced here with the discovery of many novel <italic>CACNA1G</italic> variants associated to neurological conditions. We and others have shown that APC experiments using the SyncroPatch PE384 are reliable in transposing electrophysiological parameters to study voltage-gated sodium and potassium channels, provided that appropriate guidelines are followed (<xref ref-type="bibr" rid="B12">Glazer et al., 2020</xref>; <xref ref-type="bibr" rid="B22">Montnach et al., 2021</xref>; <xref ref-type="bibr" rid="B25">Oliveira-Mendes et al., 2023</xref>). T-type Ca<sub>v</sub>3 calcium channels are particularly well suited for APC investigations as only the pore channel protein (Ca<sub>v</sub>&#x3b1;<sub>1</sub>) is required to produce a native-like T-type calcium current (<xref ref-type="bibr" rid="B6">Chemin et al., 2002</xref>; <xref ref-type="bibr" rid="B26">Perez-Reyes, 2003</xref>). Indeed, APC was recently used to study 57 variants of the Ca<sub>v</sub>3.3 channel identified in a large schizophrenia cohort (<xref ref-type="bibr" rid="B2">Baez-Nieto et al., 2022</xref>). Here, we have also successfully used APC to characterize 18 Ca<sub>v</sub>3.1 variants found in patients with neurological phenotype, especially 8 VUS (p.R102Q, p.V184G, p.N1200S, p.S1263A, p.R1718G, p.R1813W, p.V1835M, and p.D2242N) that are being studied at the functional level for the first time. Our study validates that MPC experimental conditions could be adequately transposed to APC for Ca<sub>v</sub>3.1 study. Importantly, the gating defects observed for the <italic>de novo</italic> IG variants (S5-S6 segments) using MPC, i.e., slow inactivation and deactivation kinetics, hyperpolarizing shift of steady-state activation and inactivation properties (<xref ref-type="bibr" rid="B7">Chemin et al., 2018</xref>; <xref ref-type="bibr" rid="B3">Berecki et al., 2020</xref>; <xref ref-type="bibr" rid="B27">Qebibo et al., 2024</xref>) were accurately replicated in APC experiments (<xref ref-type="fig" rid="F2">Figures 2</xref>, <xref ref-type="fig" rid="F3">3</xref>). This was also validated for the other variants studied in both MPC and APC experiments. APC offers the advantage of recording a large number of cells, blindly, for each condition (variant), which is well-suited for measuring the variant current density. While some variants displayed increased current density, our study also points to a few variants showing very low current density. The surface expression and/or stability at the plasma membrane might be affected for some of these variants resulting in reduced, or increased, current densities. Possibly, substitution of Met197 with Arg may result in a constrained flexibility of the intracellular S4-S5 linker and altered gating (with reduced current). Further studies will be needed to investigate all the potential mechanisms underlying alteration in the current density. According to our quality control criteria, low expressing (LOF) variants resulted in a small number of cells that could be accurately studied in APC. The difficulty in studying LOF variants may be a caveat when examining large series of variants using APC only. Increasing the number of APC recordings for variants with small currents should favor their analysis to a standard similar to that achieved using MPC. In addition, to better assess how the data correlate between in MPC and APC experiments, future studies should study the impact of some of the specific requirements in APC recording conditions, e.g., the concentration of 5.2&#xa0;mM external calcium, on the negative shift of activation and inactivation, as well as on the kinetics of activation and inactivation considering that external calcium concentration has been shown to influence Cav3 channel gating (<xref ref-type="bibr" rid="B17">Lacinova et al., 2006</xref>; <xref ref-type="bibr" rid="B5">Cazade et al., 2017</xref>). Overall, the APC and MPC approaches were highly complementary in providing a comprehensive electrophysiological analysis of our large series of Ca<sub>v</sub>3.1 variants.</p>
</sec>
<sec id="s4-2">
<title>Deciphering the gain/loss of channel activity in support of GOF or LOF variants</title>
<p>Several GOF variants in <italic>CACNA1G</italic> (<italic>de novo</italic>, missense mutations) are now linked to a variety of neurological and neurodevelopmental diseases with some severe conditions such as SCA42ND (<xref ref-type="bibr" rid="B7">Chemin et al., 2018</xref>; <xref ref-type="bibr" rid="B27">Qebibo et al., 2024</xref>). Deciphering the electrophysiological alterations caused by these mutations in the Ca<sub>v</sub>3.1 channels is necessary to better document the disease mechanism(s) and identify potential therapeutic opportunities. The electrophysiological criteria supporting a gain of channel activity are the increase in current density, the hyperpolarizing shift of the steady-state activation curve, the slower inactivation and deactivation kinetics and the increased window current (<xref ref-type="bibr" rid="B7">Chemin et al., 2018</xref>; <xref ref-type="bibr" rid="B3">Berecki et al., 2020</xref>; <xref ref-type="bibr" rid="B27">Qebibo et al., 2024</xref>). In turn, lower current density, slower recovery from inactivation, and a hyperpolarized steady-state inactivation curve are indicative of loss of channel activity (<xref ref-type="bibr" rid="B7">Chemin et al., 2018</xref>; <xref ref-type="bibr" rid="B27">Qebibo et al., 2024</xref>). To date, most analyses of the channel variants&#x2019; gain/loss of channel activity are performed in heterologous expression systems, e.g., in transfected HEK-293 cells (as here), without considering some specificities of the native distribution of the studied channel. Recently, neuronal modeling was used to support MPC findings for several Cav3 variants and mutants (<xref ref-type="bibr" rid="B4">Blesneac et al., 2015</xref>; <xref ref-type="bibr" rid="B8">Coutelier et al., 2015</xref>; <xref ref-type="bibr" rid="B7">Chemin et al., 2018</xref>; <xref ref-type="bibr" rid="B11">El Ghaleb et al., 2021</xref>; <xref ref-type="bibr" rid="B2">Baez-Nieto et al., 2022</xref>; <xref ref-type="bibr" rid="B27">Qebibo et al., 2024</xref>). Ca<sub>v</sub>3.1 is highly expressed in several cerebellar neurons, especially in the deep cerebellar nucleus (DCN), for which virtual neuron models have been developed (<xref ref-type="bibr" rid="B9">Destexhe et al., 1996</xref>; <xref ref-type="bibr" rid="B1">Anwar et al., 2012</xref>; <xref ref-type="bibr" rid="B30">Sudhakar et al., 2015</xref>). We show here that the use of computed neuronal excitability (<xref ref-type="bibr" rid="B30">Sudhakar et al., 2015</xref>) allowed us to pinpoint the gain/loss of channel properties for the eighteen variants explored in this study either in MPC, APC or both. Coupling APC and MPC data with <italic>in silico</italic> neuronal modeling appears to be a robust and complementary method for classifying Ca<sub>v</sub>3.1 variants. This approach further described the two recurrent SCA42ND variants p.A961T and p.M1531V as GOF variants.</p>
<p>In this study, we also report that the &#x2018;gain/loss of channel activity&#x2019; toolbox could be completed with action potential (AP) clamp experiments. AP clamp experiments were performed in HEK-293 cells with neuronal activities originating from cells known to express Ca<sub>v</sub>3.1 (cerebellar and thalamic neurons) as voltage commands (<xref ref-type="bibr" rid="B6">Chemin et al., 2002</xref>). The GOF ability of the two SCA42ND variants p.A961T and p.M1531V was retrieved both using tonic firing (Purkinje neuron) and rebound burst firing (thalamic neuron). The two other IG variants examined here, p.V392M and p.G1534D, both displayed reduced activity with tonic firing voltage command, while p.G1534D, but not p.V392M, showed increased calcium entry in rebound burst firing. Overall, <italic>in silico</italic> modeling and AP clamp experiments revealed that at the functional level, the GOF properties of the variants are intimately associated with the specific electrophysiological signature of cells expressing the Ca<sub>v</sub>3.1 channel. Our study demonstrates that these experiments add to the variant characterization pipeline by contributing to a better classification of channel variants. To characterize further the GOF/LOF properties of <italic>CACNA1G</italic> variants, <italic>in vivo</italic> studies will also be instrumental. However, this will require the development of appropriate models (human iPSC-derived cellular models or animal models) to take into account the diversity of channel variants, while complying with the 3R rule (<xref ref-type="bibr" rid="B10">Diaz et al., 2020</xref>).</p>
</sec>
</sec>
<sec id="s5">
<title>Limitations of the study and perspectives</title>
<p>In the present study, the main Cav3.1 variant-specific electrophysiological properties (i.e., inactivation kinetics and voltage-dependence of activation and inactivation) were successfully described using APC. In future studies, APC protocols, adapted here from standard MPC protocols should be further optimized to enable a more in-depth and accurate analysis of Cav3 variants, towards improving the classification of these variants. One limitation of our APC approach was in best characterizing some of the current properties (peak conductance, V<sub>Rev</sub>) for variants showing low current amplitude or low percentage of positive cells. This issue could be overcome by recording a larger number of cells in transient transfection assays or by creating high-expressing cell lines for each variant. The use of 5.2&#xa0;mM external Ca<sup>2&#x2b;</sup> concentration, a recommended technical guideline for our APC platform, may also be modified either to a more physiological external Ca<sup>2&#x2b;</sup> concentration (&#x223c;2&#xa0;mM) or to a higher external Ca<sup>2&#x2b;</sup> concentration (10&#xa0;mM). Higher external Ca<sup>2&#x2b;</sup> would expectedly favor a more accurate V<sub>Rev</sub> determination for improved current-voltage fitting and overall adjustment of the APC quality control criteria, enabling also the study of any potential changes in Ca<sup>2&#x2b;</sup> modulation (permeation, facilitation) among variants. A similar validation process may also be necessary when setting up biophysical analyses of channel variants with other APC platforms. While MPC remains valuable for in-depth analysis, variant classification should greatly benefit from every improvement made in APC experiments in future studies.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s6">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec sec-type="author-contributions" id="s7">
<title>Author contributions</title>
<p>AD: Formal Analysis, Writing &#x2013; review and editing, Methodology, Writing &#x2013; original draft, Data curation, Conceptualization, Investigation, Validation. LC: Formal Analysis, Writing &#x2013; original draft, Validation, Data curation, Resources, Methodology, Investigation, Writing &#x2013; review and editing. BRO-M: Conceptualization, Methodology, Formal Analysis, Investigation, Validation, Data curation, Visualization, Writing &#x2013; review and editing, Supervision, Writing &#x2013; original draft. CB: Methodology, Investigation, Writing &#x2013; review and editing. NB: Methodology, Investigation, Writing &#x2013; review and editing, Data curation. Jerome JM: Validation, Writing &#x2013; review and editing, Formal Analysis, Methodology, Supervision, Data curation, Software, Conceptualization, Investigation. SV: Resources, Writing &#x2013; review and editing, Investigation. MaD: Writing &#x2013; review and editing, Investigation, Resources. LB: Resources, Investigation, Writing &#x2013; review and editing. VC: Formal Analysis, Validation, Data curation, Methodology, Writing &#x2013; review and editing, Investigation, Conceptualization. NW: Writing &#x2013; review and editing, Supervision, Validation. SN: Validation, Supervision, Writing &#x2013; review and editing. AM: Validation, Writing &#x2013; review and editing, Supervision. MiD: Project administration, Funding acquisition, Resources, Data curation, Formal Analysis, Validation, Writing &#x2013; review and editing, Conceptualization, Supervision, Methodology. PL: Investigation, Writing &#x2013; review and editing, Software, Supervision, Funding acquisition, Conceptualization, Writing &#x2013; original draft, Formal Analysis, Data curation, Resources, Visualization, Methodology, Project administration, Validation.</p>
</sec>
<sec sec-type="funding-information" id="s8">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This research was funded by Labex &#x201c;Ion Channel Science and Therapeutics&#x201d; (ICST) and Agence Nationale de la Recherche (ANR-11-LABX-0015) and &#x2018;Conna&#xee;tre les Syndromes C&#xe9;r&#xe9;belleux&#x2019; (CSC) Association (to P.L and L.B). LC was supported by a Barrande PhD fellowship (Campus France).</p>
</sec>
<ack>
<p>The authors thank Angela Sun (University of Washington, Seattle, USA) and Julia Rankin (Royal Devon and Exeter Hospital, Wonford, UK) and all the clinicians involved in recruiting the cases presented in this study.</p>
</ack>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s10">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="s12">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2025.1613072/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fphar.2025.1613072/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.pdf" id="SM1" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anwar</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>De Schutter</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Controlling Ca2&#x2b;-activated K&#x2b; channels with models of Ca2&#x2b; buffering in Purkinje cells</article-title>. <source>Cerebellum</source> <volume>11</volume>, <fpage>681</fpage>&#x2013;<lpage>693</lpage>. <pub-id pub-id-type="doi">10.1007/s12311-010-0224-3</pub-id>
<pub-id pub-id-type="pmid">20981513</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baez-Nieto</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Akers-Campbell</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Budnik</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Pupo</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Analysing an allelic series of rare missense variants of CACNA1I in a Swedish schizophrenia cohort</article-title>. <source>Brain</source> <volume>145</volume>, <fpage>1839</fpage>&#x2013;<lpage>1853</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awab443</pub-id>
<pub-id pub-id-type="pmid">34919654</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berecki</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Helbig</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Ware</surname>
<given-names>T. L.</given-names>
</name>
<name>
<surname>Grinton</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Skraban</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Marsh</surname>
<given-names>E. D.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Novel missense CACNA1G mutations associated with infantile-onset developmental and epileptic encephalopathy</article-title>. <source>Int. J. Mol. Sci.</source> <volume>21</volume>, <fpage>6333</fpage>. <pub-id pub-id-type="doi">10.3390/ijms21176333</pub-id>
<pub-id pub-id-type="pmid">32878331</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blesneac</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Chemin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bidaud</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Huc-Brandt</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vandermoere</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Lory</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Phosphorylation of the Cav3.2 T-type calcium channel directly regulates its gating properties</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>112</volume>, <fpage>13705</fpage>&#x2013;<lpage>13710</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1511740112</pub-id>
<pub-id pub-id-type="pmid">26483470</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cazade</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bidaud</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Lory</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Chemin</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Activity-dependent regulation of T-type calcium channels by submembrane calcium ions</article-title>. <source>Elife</source> <volume>21</volume> (<issue>6</issue>), <fpage>e22331</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.22331</pub-id>
<pub-id pub-id-type="pmid">28109159</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chemin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Monteil</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Perez-Reyes</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bourinet</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Nargeot</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lory</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Specific contribution of human T-type calcium channel isotypes (alpha(1G), alpha(1H) and alpha(1I)) to neuronal excitability</article-title>. <source>J. Physiol.</source> <volume>540</volume>, <fpage>3</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2001.013269</pub-id>
<pub-id pub-id-type="pmid">11927664</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chemin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Siquier-Pernet</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nicouleau</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Barcia</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Medina-Cano</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>
<italic>De novo</italic> mutation screening in childhood-onset cerebellar atrophy identifies gain-of-function mutations in the CACNA1G calcium channel gene</article-title>. <source>Brain</source> <volume>141</volume>, <fpage>1998</fpage>&#x2013;<lpage>2013</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awy145</pub-id>
<pub-id pub-id-type="pmid">29878067</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coutelier</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Blesneac</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Monteil</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Monin</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Ando</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mundwiller</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>A recurrent mutation in CACNA1G alters Cav3.1 T-type calcium-channel conduction and causes autosomal-dominant cerebellar ataxia</article-title>. <source>Am. J. Hum. Genet.</source> <volume>97</volume>, <fpage>726</fpage>&#x2013;<lpage>737</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2015.09.007</pub-id>
<pub-id pub-id-type="pmid">26456284</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Destexhe</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Contreras</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Steriade</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sejnowski</surname>
<given-names>T. J.</given-names>
</name>
<name>
<surname>Huguenard</surname>
<given-names>J. R.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>
<italic>In vivo</italic>, <italic>in vitro</italic>, and computational analysis of dendritic calcium currents in thalamic reticular neurons</article-title>. <source>J. Neurosci.</source> <volume>16</volume>, <fpage>169</fpage>&#x2013;<lpage>185</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.16-01-00169.1996</pub-id>
<pub-id pub-id-type="pmid">8613783</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diaz</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zambrano</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Flores</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Contreras</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Crispin</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Aleman</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Ethical considerations in animal research: the principle of 3R&#x27;s</article-title>. <source>Rev. Invest Clin.</source> <volume>73</volume>, <fpage>199</fpage>&#x2013;<lpage>209</lpage>. <pub-id pub-id-type="doi">10.24875/RIC.20000380</pub-id>
<pub-id pub-id-type="pmid">33090120</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>El Ghaleb</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Schneeberger</surname>
<given-names>P. E.</given-names>
</name>
<name>
<surname>Fernandez-Quintero</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Geisler</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Pelizzari</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Polstra</surname>
<given-names>A. M.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>CACNA1I gain-of-function mutations differentially affect channel gating and cause neurodevelopmental disorders</article-title>. <source>Brain</source> <volume>144</volume>, <fpage>2092</fpage>&#x2013;<lpage>2106</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awab101</pub-id>
<pub-id pub-id-type="pmid">33704440</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glazer</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Wada</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Muhammad</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kalash</surname>
<given-names>O. R.</given-names>
</name>
<name>
<surname>O&#x27;neill</surname>
<given-names>M. J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>High-throughput reclassification of SCN5A variants</article-title>. <source>Am. J. Hum. Genet.</source> <volume>107</volume>, <fpage>111</fpage>&#x2013;<lpage>123</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2020.05.015</pub-id>
<pub-id pub-id-type="pmid">32533946</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hines</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Carnevale</surname>
<given-names>N. T.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>The NEURON simulation environment</article-title>. <source>Neural comput.</source> <volume>9</volume>, <fpage>1179</fpage>&#x2013;<lpage>1209</lpage>. <pub-id pub-id-type="doi">10.1162/neco.1997.9.6.1179</pub-id>
<pub-id pub-id-type="pmid">9248061</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huguenard</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Prince</surname>
<given-names>D. A.</given-names>
</name>
</person-group> (<year>1992</year>). <article-title>A novel T-type current underlies prolonged Ca(2&#x2b;)-dependent burst firing in GABAergic neurons of rat thalamic reticular nucleus</article-title>. <source>J. Neurosci.</source> <volume>12</volume>, <fpage>3804</fpage>&#x2013;<lpage>3817</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.12-10-03804.1992</pub-id>
<pub-id pub-id-type="pmid">1403085</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Richardson</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Farr</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>Ullah</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kroncke</surname>
<given-names>B. M.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>A calibrated functional patch-clamp assay to enhance clinical variant interpretation in KCNH2-related long QT syndrome</article-title>. <source>Am. J. Hum. Genet.</source> <volume>109</volume>, <fpage>1199</fpage>&#x2013;<lpage>1207</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2022.05.002</pub-id>
<pub-id pub-id-type="pmid">35688147</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kosmicki</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Samocha</surname>
<given-names>K. E.</given-names>
</name>
<name>
<surname>Howrigan</surname>
<given-names>D. P.</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Slowikowski</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lek</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Refining the role of <italic>de novo</italic> protein-truncating variants in neurodevelopmental disorders by using population reference samples</article-title>. <source>Nat. Genet.</source> <volume>49</volume>, <fpage>504</fpage>&#x2013;<lpage>510</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3789</pub-id>
<pub-id pub-id-type="pmid">28191890</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lacinov&#xe1;</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>M Kurejov&#xe1;</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>N Klugbauer</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>F Hofmann</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Gating of the expressed T-type Cav3.1 calcium channels is modulated by Ca2&#x2b;</article-title>. <source>Acta Physiol. (Oxf)</source> <volume>186</volume> (<issue>4</issue>), <fpage>249</fpage>&#x2013;<lpage>260</lpage>. <pub-id pub-id-type="doi">10.1111/j.1748-1716.2006.01539.x</pub-id>
<pub-id pub-id-type="pmid">16634780</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lory</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Nicole</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Monteil</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Neuronal Cav3 channelopathies: recent progress and perspectives</article-title>. <source>Pflugers Arch.</source> <volume>472</volume>, <fpage>831</fpage>&#x2013;<lpage>844</lpage>. <pub-id pub-id-type="doi">10.1007/s00424-020-02429-7</pub-id>
<pub-id pub-id-type="pmid">32638069</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lukacs</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Pesti</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Foldi</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Zboray</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Toth</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Papp</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>An advanced automated patch clamp protocol design to investigate drug-ion channel binding dynamics</article-title>. <source>Front. Pharmacol.</source> <volume>12</volume>, <fpage>738260</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2021.738260</pub-id>
<pub-id pub-id-type="pmid">34658875</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>J. G.</given-names>
</name>
<name>
<surname>Vandenberg</surname>
<given-names>J. I.</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>C. A.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Development of automated patch clamp assays to overcome the burden of variants of uncertain significance in inheritable arrhythmia syndromes</article-title>. <source>Front. Physiol.</source> <volume>14</volume>, <fpage>1294741</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2023.1294741</pub-id>
<pub-id pub-id-type="pmid">38089476</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>J. G.</given-names>
</name>
<name>
<surname>O&#x27;neill</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Richardson</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Thomson</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Ingles</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Muhammad</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Multisite validation of a functional assay to adjudicate SCN5A Brugada syndrome-associated variants</article-title>. <source>Circ. Genom Precis. Med.</source> <volume>17</volume>, <fpage>e004569</fpage>. <pub-id pub-id-type="doi">10.1161/CIRCGEN.124.004569</pub-id>
<pub-id pub-id-type="pmid">38953211</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Montnach</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lorenzini</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lesage</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Nicolas</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Moreau</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Computer modeling of whole-cell voltage-clamp analyses to delineate guidelines for good practice of manual and automated patch-clamp</article-title>. <source>Sci. Rep.</source> <volume>11</volume>, <fpage>3282</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-021-82077-8</pub-id>
<pub-id pub-id-type="pmid">33558601</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ng</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Farr</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Windley</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Perry</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>A. P.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Heterozygous KCNH2 variant phenotyping using Flp-In HEK293 and high-throughput automated patch clamp electrophysiology</article-title>. <source>Biol. Methods Protoc.</source> <volume>6</volume>, <fpage>bpab003</fpage>. <pub-id pub-id-type="doi">10.1093/biomethods/bpab003</pub-id>
<pub-id pub-id-type="pmid">33884304</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Obergrussberger</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rinke-Weiss</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Goetze</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Rapedius</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Brinkwirth</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>The suitability of high throughput automated patch clamp for physiological applications</article-title>. <source>J. Physiol.</source> <volume>600</volume>, <fpage>277</fpage>&#x2013;<lpage>297</lpage>. <pub-id pub-id-type="doi">10.1113/JP282107</pub-id>
<pub-id pub-id-type="pmid">34555195</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oliveira-Mendes</surname>
<given-names>B. B. R.</given-names>
</name>
<name>
<surname>Alameh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Montnach</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ollivier</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gibaud</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Feliciangeli</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Predicting hERG repolarization power at 37 &#xb0;C from recordings at room temperature</article-title>. <source>Clin. Transl. Med.</source> <volume>13</volume>, <fpage>e1266</fpage>. <pub-id pub-id-type="doi">10.1002/ctm2.1266</pub-id>
<pub-id pub-id-type="pmid">37199999</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perez-Reyes</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Molecular physiology of low-voltage-activated t-type calcium channels</article-title>. <source>Physiol. Rev.</source> <volume>83</volume>, <fpage>117</fpage>&#x2013;<lpage>161</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00018.2002</pub-id>
<pub-id pub-id-type="pmid">12506128</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qebibo</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Davakan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nesson-Dauphin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Boulali</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Siquier-Pernet</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Afenjar</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>The characterization of new <italic>de novo</italic> CACNA1G variants affecting the intracellular gate of Cav3.1 channel broadens the spectrum of neurodevelopmental phenotypes in SCA42ND</article-title>. <source>Genet. Med.</source> <volume>27</volume>, <fpage>101337</fpage>. <pub-id pub-id-type="doi">10.1016/j.gim.2024.101337</pub-id>
<pub-id pub-id-type="pmid">39674904</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raman</surname>
<given-names>I. M.</given-names>
</name>
<name>
<surname>Bean</surname>
<given-names>B. P.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Resurgent sodium current and action potential formation in dissociated cerebellar Purkinje neurons</article-title>. <source>J. Neurosci.</source> <volume>17</volume>, <fpage>4517</fpage>&#x2013;<lpage>4526</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.17-12-04517.1997</pub-id>
<pub-id pub-id-type="pmid">9169512</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riquet</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cleuziou</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Floret</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Quesque</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Defoort</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Smol</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Paroxysmal tonic Upgaze in a patient with congenital ataxia due to a <italic>de novo</italic> missense variant of CACNA1G</article-title>. <source>Pediatr. Neurol.</source> <volume>139</volume>, <fpage>22</fpage>&#x2013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2022.11.003</pub-id>
<pub-id pub-id-type="pmid">36508879</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sudhakar</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Torben-Nielsen</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>De Schutter</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Cerebellar nuclear neurons Use time and rate Coding to transmit Purkinje neuron Pauses</article-title>. <source>PLoS Comput. Biol.</source> <volume>11</volume>, <fpage>e1004641</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pcbi.1004641</pub-id>
<pub-id pub-id-type="pmid">26630202</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vanoye</surname>
<given-names>C. G.</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Desai</surname>
<given-names>R. R.</given-names>
</name>
<name>
<surname>Dekeyser</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rasmussen-Torvik</surname>
<given-names>L. J.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Functional evaluation of human ion channel variants using automated electrophysiology</article-title>. <source>Methods Enzymol.</source> <volume>654</volume>, <fpage>383</fpage>&#x2013;<lpage>405</lpage>. <pub-id pub-id-type="doi">10.1016/bs.mie.2021.02.011</pub-id>
<pub-id pub-id-type="pmid">34120723</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vanoye</surname>
<given-names>C. G.</given-names>
</name>
<name>
<surname>Desai</surname>
<given-names>R. R.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Adusumilli</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jairam</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ghabra</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>High-throughput evaluation of epilepsy-associated KCNQ2 variants reveals functional and pharmacological heterogeneity</article-title>. <source>JCI Insight</source> <volume>7</volume>, <fpage>e156314</fpage>. <pub-id pub-id-type="doi">10.1172/jci.insight.156314</pub-id>
<pub-id pub-id-type="pmid">35104249</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yajuan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhiyuan</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>A comparison of the performance and application differences between manual and automated patch-clamp techniques</article-title>. <source>Curr. Chem. Genomics</source> <volume>6</volume>, <fpage>87</fpage>&#x2013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.2174/1875397301206010087</pub-id>
<pub-id pub-id-type="pmid">23346269</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zamponi</surname>
<given-names>G. W.</given-names>
</name>
<name>
<surname>Striessnig</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Koschak</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dolphin</surname>
<given-names>A. C.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>The physiology, Pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential</article-title>. <source>Pharmacol. Rev.</source> <volume>67</volume>, <fpage>821</fpage>&#x2013;<lpage>870</lpage>. <pub-id pub-id-type="doi">10.1124/pr.114.009654</pub-id>
<pub-id pub-id-type="pmid">26362469</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Cryo-EM structures of apo and antagonist-bound human Ca(v)3.1</article-title>. <source>Nature</source> <volume>576</volume>, <fpage>492</fpage>&#x2013;<lpage>497</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-019-1801-3</pub-id>
<pub-id pub-id-type="pmid">31766050</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>